Citius Oncology - 53 Year Dividend History | CTOR
Historical dividend payout and yield for Citius Oncology (CTOR) since 1971. The current TTM dividend payout for Citius Oncology (CTOR) as of September 17, 2024 is $0.00. The current dividend yield for Citius Oncology as of September 17, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.004B |
$0.000B |
|
Citius Oncology Inc. platform to develop and commercialize novel targeted oncology therapies. The company is seeking approval from the U.S. Food and Drug Administration of LYMPHIR(TM) for an orphan indication in the treatment of persistent or recurrent cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. Citius Oncology Inc., formerly known as TenX Keane Acquisition, is based in New York.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
